Clinical TrialsSearch results for "enfortumab"
Number of results: 27
Not yet recruiting
- A study of ASP2998 given by itself and given with standard therapies in people with solid tumors
- Locally advanced or metastatic malignant solid tumors
- Gupta Anumeha
- 2026-02-17
Recruiting
- An Open-Label, Single-Arm Phase II Study of <em>Enfortumab</em> Vedotin Plus Pembrolizumab in Patients with Unresectable Urothelial Carcinoma
- Urothelial Carcinoma
- Kanazawa University
- 2026-01-06
Not yet recruiting
- A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Carcinoma, Transitional Cell Urinary Bladder Neoplasms Neoplasm Metastasis
- Masaki Takeshi
- 2025-12-01
Recruiting
- Study of Datopotamab Deruxtecan plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Participants with Locally Advanced or Metastatic Urothelial Carcinoma
- Urothelial Cancer, Bladder cancer
- Inoguchi Akihiro
- 2025-10-17
Recruiting
- NCCH2412/MK015 Trial
- Small Bowel Adenocarcinoma
- Kato Ken
- 2025-10-09
Recruiting
- Biweekly Combination therapy of Urothelial carcinoma with Regimen Evaluation
- Patients with unresectable urothelial carcinoma
- Izumi Kouji
- 2025-10-07
Recruiting
- Efficacy of Prophylactic Topical Steroid Administration for <em>Enfortumab</em> Vedotin-Related Cutaneous Toxicity
- Urothelial carcinoma
- Kita Yuki
- 2024-12-13
No Longer Recruiting
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Metastatic Solid Tumor Recurrent Solid Tumor Advanced Solid Tumor
- Masaki Takeshi
- 2024-08-28
Recruiting
- A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
- Metastatic Solid Tumor Recurrent Solid Tumor Advanced Solid Tumor
- Masaki Takeshi
- 2024-05-14
Completed
- A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- * Neoplasms * Non-small-cell Lung Cancer * Urothelial Carcinoma * (and 5 more...)
- Kawai Norisuke
- 2024-03-28